Abstract | PURPOSE: METHODS: We enrolled children into 2 prospective, randomized multicenter clinical trials of amblyopia therapy. Herein we report the results for severe amblyopia, 20/125 to 20/400. In Trial 1, 60 children 3 to 6 years of age (mean, 4.4 years) were randomized to weekend atropine plus a plano lens or weekend atropine plus full spectacle correction for the sound eye. In Trial 2, 40 children 7 to 12 years of age (mean, 9.3 years) were randomized to weekend atropine or 2 hours of daily patching. The visual acuity outcome was assessed at 18 weeks in Trial 1 and 17 weeks in Trial 2. RESULTS: In Trial 1, visual acuity improved by an average of 4.5 lines in the atropine plus correction group (95% CI, 3.2-5.8 lines) and 5.1 lines in the atropine plus plano lens group (95% CI, 3.7-6.4 lines). In Trial 2, visual acuity improved by an average of 1.5 lines in the atropine group (95% CI, 0.5-2.5 lines) and 1.8 lines in the patching group (95% CI, 1.1-2.6 lines). CONCLUSIONS: Weekend atropine can improve visual acuity in children 3 to 12 years of age with severe amblyopia. Improvement may be greater in younger children.
|
Authors | Michael X Repka, Raymond T Kraker, Roy W Beck, Eileen Birch, Susan A Cotter, Jonathan M Holmes, Richard W Hertle, Darren L Hoover, Deborah L Klimek, Wendy Marsh-Tootle, Mitchell M Scheiman, Donny W Suh, David R Weakley, Pediatric Eye Disease Investigator Group |
Journal | Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus
(J AAPOS)
Vol. 13
Issue 3
Pg. 258-63
(Jun 2009)
ISSN: 1528-3933 [Electronic] United States |
PMID | 19541265
(Publication Type: Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, N.I.H., Extramural)
|
Chemical References |
- Ophthalmic Solutions
- Parasympatholytics
- Atropine
|
Topics |
- Adolescent
- Amblyopia
(drug therapy)
- Atropine
(administration & dosage)
- Bandages
- Child
- Child, Preschool
- Drug Administration Schedule
- Female
- Humans
- Male
- Ophthalmic Solutions
(administration & dosage)
- Parasympatholytics
(administration & dosage)
- Pilot Projects
- Prospective Studies
- Severity of Illness Index
- Strabismus
(complications)
- Treatment Outcome
- Visual Acuity
(drug effects)
|